NCT07141563 2026-01-07
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Completed
Bristol-Myers Squibb
Aetion, Inc.
Aetion, Inc.
Tianjin Medical University Cancer Institute and Hospital
Eli Lilly and Company
Eli Lilly and Company